What is Healthcare Triangle Inc share price today?

Healthcare Triangle Inc (HCTI) share price today is {{live_price}}.

Can Indians buy Healthcare Triangle Inc shares?

Yes, Indians can invest in the Healthcare Triangle Inc (HCTI) from India. With INDmoney, you can buy Healthcare Triangle Inc at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Healthcare Triangle Inc at zero transaction cost.

How can I buy Healthcare Triangle Inc shares from India?

It is very easy to buy Healthcare Triangle Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Healthcare Triangle Inc be purchased?

Yes, you can buy fractional shares of Healthcare Triangle Inc with INDmoney app.

What are the documents required to start investing in Healthcare Triangle Inc stocks?

To start investing in Healthcare Triangle Inc, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Healthcare Triangle Inc

Today’s highest price of Healthcare Triangle Inc (HCTI) is {{1_rba_end}}. Today’s lowest price of Healthcare Triangle Inc (HCTI) is {{1_rba_st}}.

What is today's market capitalisation of Healthcare Triangle Inc

Today's market capitalisation of Healthcare Triangle Inc HCTI is 2.9M

What is the 52 Week High and Low Range of Healthcare Triangle Inc

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Healthcare Triangle Inc is down from its 52 Week High?

Healthcare Triangle Inc (HCTI) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Healthcare Triangle Inc is up from its 52 Week low?

Healthcare Triangle Inc (HCTI) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Healthcare Triangle Inc?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Healthcare Triangle Inc

Mr. Thyagarajan Ramachandran is the current Chief Executive Officer (CEO) of Healthcare Triangle Inc.

Home>
US Stocks>
Healthcare Triangle Inc

Healthcare Triangle Inc (HCTI)

$0.33

-0.18

(-35.59%)▲

Market is closed - opens 7 PM, 16 Sep 2024

Performance

$0.29
$0.52
$0.33
11.91%
Downside
Day's Volatility :44.1%
Upside
36.54%
$0.29
$4.87
$0.33
12.12%
Downside
52 Weeks Volatility :94.05%
Upside
93.22%

Returns

Period	Healthcare Triangle Inc	Index (Russel 2000)
3 Months	-50.67%	0.0%
6 Months	-82.17%	0.0%
1 Year	-92.43%	0.0%
3 Years	-99.08%	-20.0%

Highlights

Market Capitalization	2.9M
Book Value	- $0.11
Earnings Per Share (EPS)	-2.41
Wall Street Target Price	1.5

Profit Margin	-48.55%
Operating Margin TTM	-46.18%

Return On Assets TTM	-54.5%
Return On Equity TTM	-287.56%

Revenue TTM	21.9M
Revenue Per Share TTM	4.81
Quarterly Revenue Growth YOY	-65.0%
Gross Profit TTM	10.5M
EBITDA	-3.4M
Diluted Eps TTM	-2.41
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	0.0
EPS Estimate Next Year	0.0
EPS Estimate Current Quarter	0.0
EPS Estimate Next Quarter	0.0

Analyst Recommendation

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Healthcare Triangle Inc(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 354.55%

Current $0.33

Target $1.50

Company Financials

	FY16	Y/Y Change
Revenue	232.4K	↑ 3895.86%
Net Income	-4.6M	↓ 31.99%
Net Profit Margin	-2.0K%	↑ 113787.27%

	FY19	Y/Y Change
Revenue	28.7M	↑ 12267.33%
Net Income	1.2M	↓ 125.6%
Net Profit Margin	4.08%	↑ 1974.28%

	FY20	Y/Y Change
Revenue	31.3M	↑ 9.06%
Net Income	2.4M	↑ 100.79%
Net Profit Margin	7.51%	↑ 3.43%

	FY21	Y/Y Change
Revenue	35.3M	↑ 12.54%
Net Income	-6.0M	↓ 352.82%
Net Profit Margin	-16.87%	↓ 24.38%

	FY22	Y/Y Change
Revenue	45.9M	↑ 30.1%
Net Income	-9.6M	↑ 61.51%
Net Profit Margin	-20.94%	↓ 4.07%

	FY23	Y/Y Change
Revenue	33.2M	↓ 27.64%
Net Income	-12.3M	↑ 28.4%
Net Profit Margin	-37.16%	↓ 16.22%

	Q1 FY23	Q/Q Change
Revenue	9.8M	↓ 12.88%
Net Income	-3.3M	↓ 32.59%
Net Profit Margin	-33.32%	↑ 9.75%

	Q2 FY23	Q/Q Change
Revenue	8.5M	↓ 13.34%
Net Income	-1.8M	↓ 45.52%
Net Profit Margin	-20.95%	↑ 12.37%

	Q3 FY23	Q/Q Change
Revenue	7.8M	↓ 8.76%
Net Income	-1.9M	↑ 8.79%
Net Profit Margin	-24.98%	↓ 4.03%

	Q4 FY23	Q/Q Change
Revenue	7.1M	↓ 9.24%
Net Income	-5.3M	↑ 174.42%
Net Profit Margin	-75.52%	↓ 50.54%

	Q1 FY24	Q/Q Change
Revenue	4.1M	↓ 41.8%
Net Income	-1.9M	↓ 65.08%
Net Profit Margin	-45.32%	↑ 30.2%

	Q2 FY24	Q/Q Change
Revenue	3.0M	↓ 27.38%
Net Income	-1.5M	↓ 18.9%
Net Profit Margin	-50.6%	↓ 5.28%

	FY16	Y/Y Change
Total Assets	2.1M	↑ 81.83%
Total Liabilities	9.9M	↑ 26.14%

	FY19	Y/Y Change
Total Assets	8.3M	↑ 288.35%
Total Liabilities	6.3M	↓ 36.45%

	FY20	Y/Y Change
Total Assets	11.1M	↑ 34.6%
Total Liabilities	6.8M	↑ 8.0%

	FY21	Y/Y Change
Total Assets	24.6M	↑ 121.58%
Total Liabilities	8.5M	↑ 25.05%

	FY22	Y/Y Change
Total Assets	20.8M	↓ 15.64%
Total Liabilities	8.4M	↓ 1.21%

	FY23	Y/Y Change
Total Assets	10.0M	↓ 51.6%
Total Liabilities	9.5M	↑ 13.56%

	Q1 FY23	Q/Q Change
Total Assets	18.9M	↓ 9.17%
Total Liabilities	9.6M	↑ 14.11%

	Q2 FY23	Q/Q Change
Total Assets	16.1M	↓ 14.8%
Total Liabilities	8.0M	↓ 16.11%

	Q3 FY23	Q/Q Change
Total Assets	14.5M	↓ 9.97%
Total Liabilities	8.3M	↑ 4.02%

	Q4 FY23	Q/Q Change
Total Assets	10.0M	↓ 30.53%
Total Liabilities	9.5M	↑ 14.05%

	Q1 FY24	Q/Q Change
Total Assets	6.9M	↓ 31.62%
Total Liabilities	7.4M	↓ 22.37%

	Q2 FY24	Q/Q Change
Total Assets	6.0M	↓ 12.38%
Total Liabilities	6.7M	↓ 9.7%

	FY16	Y/Y Change
Operating Cash Flow	-971.3K	↑ 89.11%
Investing Cash Flow	-5.0K	↓ 58.33%
Financing Cash Flow	952.5K	↑ 73.32%

	FY19	Y/Y Change
Operating Cash Flow	4.0M	↓ 508.5%
Investing Cash Flow	-3.6M	↑ 72878.82%
Financing Cash Flow	1.6M	↑ 72.19%

	FY20	Y/Y Change
Operating Cash Flow	-734.7K	↓ 118.52%
Investing Cash Flow	-477.5K	↓ 86.92%
Financing Cash Flow	1.6M	↑ 0.0%

	FY21	Y/Y Change
Operating Cash Flow	-7.3M	↑ 892.73%
Investing Cash Flow	-7.6M	↑ 1497.79%
Financing Cash Flow	15.3M	↑ 832.25%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-1.6M	↓ 27.96%
Investing Cash Flow	-2.0K	↓ 85.71%
Financing Cash Flow	533.0K	↓ 195.01%

Technicals Summary

Sell

Neutral

Buy

Healthcare Triangle Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Healthcare Triangle Inc	-37.65%	-82.17%	-92.43%	-99.08%	-99.08%
Solventum Corp	21.15%	1.3%	1.3%	1.3%	1.3%
Doximity, Inc.	10.79%	41.18%	83.05%	-61.24%	-25.81%
Veeva Systems Inc.	15.81%	-6.25%	3.22%	-27.11%	49.13%
Ge Healthcare Technologies Inc.	4.12%	-1.61%	31.68%	43.68%	43.68%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Healthcare Triangle Inc	NA	NA	NA	0.0	-2.88	-0.55	NA	-0.11
Solventum Corp	NA	NA	NA	6.26	0.17	0.08	NA	NA
Doximity, Inc.	47.78	47.78	2.42	0.9	0.17	0.11	NA	4.92
Veeva Systems Inc.	57.97	57.97	1.4	4.76	0.13	0.06	NA	32.04
Ge Healthcare Technologies Inc.	25.28	25.28	2.27	4.24	0.21	0.06	0.0	17.08

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Healthcare Triangle Inc	Buy	$2.9M	-99.08%	NA	-48.55%
Solventum Corp	Hold	$10.8B	1.3%	NA	15.73%
Doximity, Inc.	Hold	$7.1B	-25.81%	47.78	32.53%
Veeva Systems Inc.	Buy	$35.3B	49.13%	57.97	23.91%
Ge Healthcare Technologies Inc.	Buy	$39.9B	43.68%	25.28	8.1%

Insights on Healthcare Triangle Inc

Decreasing Revenue
Revenue is down for the last 8 quarters, 11.95M → 2.98M (in $), with an average decrease of 17.0% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -5.33M → -1.51M (in $), with an average increase of 104.8% per quarter
Vs DOCS
In the last 1 year, Doximity, Inc. has given 83.1% return, outperforming this stock by 175.5%